Sylvia M Nikkho (Sylvia Nikkho)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Pulmonary Hypertension

Top Venues

Pulmonary circulation

This page only lists publications with an associated author ORCID identifier.

Publications

Oksana A Shlobin, Shelley Shapiro, Stephen John Wort, Lucilla Piccari, John A Scandurra, Paul M Hassoun, Sylvia M Nikkho, Steven D Nathan
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. Pulmonary circulation 14 (1) (2024)
Oksana A Shlobin, Shelley Shapiro, Stephen John Wort, Lucilla Piccari, John A Scandurra, Paul M Hassoun, Sylvia M Nikkho, Steven D Nathan
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. Pulmonary circulation 14 (1) (2024)
Kellie Morland, Christian Gerges, Jean Elwing, Scott H Visovatti, Jason Weatherald, Kari R Gillmeyer, Adriano R Tonelli, Stephen C Mathai, Athénaïs Boucly, Paul G Williams, Sivadasanpillai Harikrishnan, Evan P Minty, Lukas Hobohm, Arun Jose, Roberto Badagliacca, Edmund M T Lau, Zhi-Cheng Jing, Rebecca R Vanderpool, Charles Fauvel, Jose Leonidas Alves, Geoff Strange, Tomas Pulido, Junyan Qian, Mengtao Li, Valentina Mercurio, Jason G E Zelt, Victor M Moles, Meghan M Cirulis, Sylvia M Nikkho, Raymond L Benza, C Gregory Elliott
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group. Pulmonary circulation 13 (4) (2023)
Kellie Morland, Christian Gerges, Jean Elwing, Scott H Visovatti, Jason Weatherald, Kari R Gillmeyer, Adriano R Tonelli, Stephen C Mathai, Athénaïs Boucly, Paul G Williams, Sivadasanpillai Harikrishnan, Evan P Minty, Lukas Hobohm, Arun Jose, Roberto Badagliacca, Edmund M T Lau, Zhi-Cheng Jing, Rebecca R Vanderpool, Charles Fauvel, Jose Leonidas Alves, Geoff Strange, Tomas Pulido, Junyan Qian, Mengtao Li, Valentina Mercurio, Jason G E Zelt, Victor M Moles, Meghan M Cirulis, Sylvia M Nikkho, Raymond L Benza, C Gregory Elliott
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group. Pulmonary circulation 13 (4) (2023)
Lucilla Piccari, Brian W Allwood, Katerina M Antoniou, Jonathan H Chung, Paul M Hassoun, Sylvia M Nikkho, Rajan Saggar, Oksana A Shlobin, Patrizio Vitulo, Steven D Nathan, Stephen John Wort
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension. Pulmonary circulation 13 (2) (2023)
Paul M Overton, Mark Toshner, Claire Mulligan, Pareen Vora, Sylvia M Nikkho, Jan de Backer, Ben R Lavon, Frederikus A Klok, null null
Pulmonary thromboembolic events in COVID-19-A systematic literature review. Pulmonary circulation 12 (3) (2022)
Steven D Nathan, Peter Fernandes, Mitchell Psotka, Patrizio Vitulo, Lucilla Piccari, Katerina M Antoniou, Sylvia M Nikkho, Norman Stockbridge
Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. Pulmonary circulation 12 (4) (2022)
Steven D Nathan, Peter Fernandes, Mitchell Psotka, Patrizio Vitulo, Lucilla Piccari, Katerina M Antoniou, Sylvia M Nikkho, Norman Stockbridge
Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. Pulmonary circulation 12 (4) (2022)
Sylvia M Nikkho, Manuel J Richter, Shelley Shapiro, Steven H Abman, Katerina Antoniou, Jonathan Chung, Peter Fernandes, Paul Hassoun, Howard M Lazarus, Horst Olschewski, Lucilla Piccari, Mitchell Psotka, Rajan Saggar, Oksana A Shlobin, Norman Stockbridge, Patrizio Vitulo, Carmine Dario Vizza, Stephen J Wort, Steven D Nathan
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension. Pulmonary circulation 12 (3) (2022)
Thenappan Thenappan, Nadine Al-Naamani, Stefano Ghio, Hossein-Ardeschir Ghofrani, Paul M Hassoun, Marc Pritzker, Adam Torbicki, Sylvia M Nikkho, Dennis Busse, Ioana R Preston
Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies. Pulmonary circulation 10 (4) (2020)